Clinical Trial Update: Phase 2 Study of CAN008 in Subjects With GBM [Phase 2]

View source ↗

Summary

Phase 2 trial update for CAN008 in newly diagnosed glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CAN008

Snippet

Sponsor: CANbridge Life Sciences Ltd. | Conditions: Newly-diagnosed Glioblastoma | Phase 2 | Status: UNKNOWN